Staphylococcus aureus adaptation to vancomycin influences phage susceptibility Article Swipe
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1016/j.resmic.2025.104341
Phages are bacterial viruses considered as therapeutics for treatment of serious infections with antibiotic-resistant pathogens. In Staphylococcus aureus, resistance to cell wall targeting antibiotics is common in the methicillin resistant (MRSA) or vancomycin-intermediate susceptible (VISA) strains. Furthermore, the cell wall anchors the primary phage receptor, the wall teichoic acid (WTA) glycopolymers. Here we demonstrate that mutations resulting in VISA development affect phage susceptibility of clinically and laboratory evolved strains. For clinical strains we observed both increased and decreased susceptibility compared to the ancestral vancomycin susceptible strains when infected with the therapeutically relevant myoviruses, ΦIPLA-RODI, Stab20, Stab21 and ΦK. For laboratory strains adapted to vancomycin from the MRSA strain, JE2, we observed variable resistance development to the phages ΦIPLA-RODI, Stab21 and ΦK with one strain becoming completely phage resistant. In contrast, half of the VISA strains became susceptible to Stab20 to which JE2 is resistant. These changes in part correlated with altered WTA glycosylation patterns as shown by WTA-specific antibodies and for the resistant strain resulted in compromised phage therapy as shown in a Galleria mellonella infection model. This study highlights the need for understanding antibiotic-driven alterations in bacterial physiology when developing phage-based therapies using combination treatments with antibiotics and phages.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.resmic.2025.104341
- OA Status
- hybrid
- References
- 54
- OpenAlex ID
- https://openalex.org/W4414568529
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4414568529Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.resmic.2025.104341Digital Object Identifier
- Title
-
Staphylococcus aureus adaptation to vancomycin influences phage susceptibilityWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-09-01Full publication date if available
- Authors
-
Jack Åke Harry Abrahamsson, Esther Lehmann, Anaëlle Fait, Rob van Dalen, Nina M. van Sorge, Hanne IngmerList of authors in order
- Landing page
-
https://doi.org/10.1016/j.resmic.2025.104341Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1016/j.resmic.2025.104341Direct OA link when available
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
54Number of works referenced by this work
Full payload
| id | https://openalex.org/W4414568529 |
|---|---|
| doi | https://doi.org/10.1016/j.resmic.2025.104341 |
| ids.doi | https://doi.org/10.1016/j.resmic.2025.104341 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/41016661 |
| ids.openalex | https://openalex.org/W4414568529 |
| fwci | 0.0 |
| type | article |
| title | Staphylococcus aureus adaptation to vancomycin influences phage susceptibility |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | 104341 |
| biblio.first_page | 104341 |
| topics[0].id | https://openalex.org/T10195 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9995999932289124 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | Antimicrobial Resistance in Staphylococcus |
| topics[1].id | https://openalex.org/T11048 |
| topics[1].field.id | https://openalex.org/fields/23 |
| topics[1].field.display_name | Environmental Science |
| topics[1].score | 0.9995999932289124 |
| topics[1].domain.id | https://openalex.org/domains/3 |
| topics[1].domain.display_name | Physical Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2303 |
| topics[1].subfield.display_name | Ecology |
| topics[1].display_name | Bacteriophages and microbial interactions |
| topics[2].id | https://openalex.org/T11288 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9991000294685364 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2725 |
| topics[2].subfield.display_name | Infectious Diseases |
| topics[2].display_name | Clostridium difficile and Clostridium perfringens research |
| is_xpac | False |
| apc_list.value | 2240 |
| apc_list.currency | USD |
| apc_list.value_usd | 2240 |
| apc_paid.value | 2240 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2240 |
| language | en |
| locations[0].id | doi:10.1016/j.resmic.2025.104341 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S37853641 |
| locations[0].source.issn | 0923-2508, 1769-7123 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0923-2508 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Research in Microbiology |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_lineage_names | Elsevier BV |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Research in Microbiology |
| locations[0].landing_page_url | https://doi.org/10.1016/j.resmic.2025.104341 |
| locations[1].id | pmid:41016661 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Research in microbiology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/41016661 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5098971965 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Jack Åke Harry Abrahamsson |
| authorships[0].countries | DK |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I124055696 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Veterinary and Animal Sciences, Section for Bacteria and Viruses, University of Copenhagen, Frederiksberg, 1870 , Copenhagen, Denmark. |
| authorships[0].institutions[0].id | https://openalex.org/I124055696 |
| authorships[0].institutions[0].ror | https://ror.org/035b05819 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I124055696 |
| authorships[0].institutions[0].country_code | DK |
| authorships[0].institutions[0].display_name | University of Copenhagen |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Jack Å.H. Abrahamsson |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Veterinary and Animal Sciences, Section for Bacteria and Viruses, University of Copenhagen, Frederiksberg, 1870 , Copenhagen, Denmark. |
| authorships[1].author.id | https://openalex.org/A5033586742 |
| authorships[1].author.orcid | https://orcid.org/0009-0006-2278-4100 |
| authorships[1].author.display_name | Esther Lehmann |
| authorships[1].countries | DK |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I124055696 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Veterinary and Animal Sciences, Section for Bacteria and Viruses, University of Copenhagen, Frederiksberg, 1870 , Copenhagen, Denmark. |
| authorships[1].institutions[0].id | https://openalex.org/I124055696 |
| authorships[1].institutions[0].ror | https://ror.org/035b05819 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I124055696 |
| authorships[1].institutions[0].country_code | DK |
| authorships[1].institutions[0].display_name | University of Copenhagen |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Esther Lehmann |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Veterinary and Animal Sciences, Section for Bacteria and Viruses, University of Copenhagen, Frederiksberg, 1870 , Copenhagen, Denmark. |
| authorships[2].author.id | https://openalex.org/A5085173624 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-0341-5426 |
| authorships[2].author.display_name | Anaëlle Fait |
| authorships[2].countries | CH, DK |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I124055696, https://openalex.org/I35440088 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Veterinary and Animal Sciences, Section for Bacteria and Viruses, University of Copenhagen, Frederiksberg, 1870 , Copenhagen, Denmark; Department of Environmental Systems Science, ETH Zürich, 8092 Zürich, Switzerland. |
| authorships[2].institutions[0].id | https://openalex.org/I35440088 |
| authorships[2].institutions[0].ror | https://ror.org/05a28rw58 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I2799323385, https://openalex.org/I35440088 |
| authorships[2].institutions[0].country_code | CH |
| authorships[2].institutions[0].display_name | ETH Zurich |
| authorships[2].institutions[1].id | https://openalex.org/I124055696 |
| authorships[2].institutions[1].ror | https://ror.org/035b05819 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I124055696 |
| authorships[2].institutions[1].country_code | DK |
| authorships[2].institutions[1].display_name | University of Copenhagen |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Anaëlle Fait |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Veterinary and Animal Sciences, Section for Bacteria and Viruses, University of Copenhagen, Frederiksberg, 1870 , Copenhagen, Denmark; Department of Environmental Systems Science, ETH Zürich, 8092 Zürich, Switzerland. |
| authorships[3].author.id | https://openalex.org/A5061995723 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-0436-6048 |
| authorships[3].author.display_name | Rob van Dalen |
| authorships[3].countries | NL |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210151833, https://openalex.org/I887064364 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Medical Microbiology and Infection Prevention, Amsterdam UMC location University of Amsterdam, Amsterdam Institute for Immunology and Infectious Diseases, 1105 AZ Amsterdam, The Netherlands. |
| authorships[3].institutions[0].id | https://openalex.org/I4210151833 |
| authorships[3].institutions[0].ror | https://ror.org/05grdyy37 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210151833 |
| authorships[3].institutions[0].country_code | NL |
| authorships[3].institutions[0].display_name | Amsterdam University Medical Centers |
| authorships[3].institutions[1].id | https://openalex.org/I887064364 |
| authorships[3].institutions[1].ror | https://ror.org/04dkp9463 |
| authorships[3].institutions[1].type | education |
| authorships[3].institutions[1].lineage | https://openalex.org/I887064364 |
| authorships[3].institutions[1].country_code | NL |
| authorships[3].institutions[1].display_name | University of Amsterdam |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Rob van Dalen |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Medical Microbiology and Infection Prevention, Amsterdam UMC location University of Amsterdam, Amsterdam Institute for Immunology and Infectious Diseases, 1105 AZ Amsterdam, The Netherlands. |
| authorships[4].author.id | https://openalex.org/A5018866235 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-2695-5863 |
| authorships[4].author.display_name | Nina M. van Sorge |
| authorships[4].countries | NL |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210151833, https://openalex.org/I887064364 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Medical Microbiology and Infection Prevention, Amsterdam UMC location University of Amsterdam, Amsterdam Institute for Immunology and Infectious Diseases, 1105 AZ Amsterdam, The Netherlands; Netherlands Reference Center for Bacterial Meningitis, Amsterdam UMC location AMC, 1105 AZ Amsterdam, The Netherlands. |
| authorships[4].institutions[0].id | https://openalex.org/I4210151833 |
| authorships[4].institutions[0].ror | https://ror.org/05grdyy37 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210151833 |
| authorships[4].institutions[0].country_code | NL |
| authorships[4].institutions[0].display_name | Amsterdam University Medical Centers |
| authorships[4].institutions[1].id | https://openalex.org/I887064364 |
| authorships[4].institutions[1].ror | https://ror.org/04dkp9463 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I887064364 |
| authorships[4].institutions[1].country_code | NL |
| authorships[4].institutions[1].display_name | University of Amsterdam |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Nina M. van Sorge |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Medical Microbiology and Infection Prevention, Amsterdam UMC location University of Amsterdam, Amsterdam Institute for Immunology and Infectious Diseases, 1105 AZ Amsterdam, The Netherlands; Netherlands Reference Center for Bacterial Meningitis, Amsterdam UMC location AMC, 1105 AZ Amsterdam, The Netherlands. |
| authorships[5].author.id | https://openalex.org/A5047092331 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-8350-5631 |
| authorships[5].author.display_name | Hanne Ingmer |
| authorships[5].countries | DK |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I124055696 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Veterinary and Animal Sciences, Section for Bacteria and Viruses, University of Copenhagen, Frederiksberg, 1870 , Copenhagen, Denmark. Electronic address: [email protected]. |
| authorships[5].institutions[0].id | https://openalex.org/I124055696 |
| authorships[5].institutions[0].ror | https://ror.org/035b05819 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I124055696 |
| authorships[5].institutions[0].country_code | DK |
| authorships[5].institutions[0].display_name | University of Copenhagen |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Hanne Ingmer |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Veterinary and Animal Sciences, Section for Bacteria and Viruses, University of Copenhagen, Frederiksberg, 1870 , Copenhagen, Denmark. Electronic address: [email protected]. |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1016/j.resmic.2025.104341 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Staphylococcus aureus adaptation to vancomycin influences phage susceptibility |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10195 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9995999932289124 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | Antimicrobial Resistance in Staphylococcus |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1016/j.resmic.2025.104341 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S37853641 |
| best_oa_location.source.issn | 0923-2508, 1769-7123 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0923-2508 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Research in Microbiology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_lineage_names | Elsevier BV |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Research in Microbiology |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.resmic.2025.104341 |
| primary_location.id | doi:10.1016/j.resmic.2025.104341 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S37853641 |
| primary_location.source.issn | 0923-2508, 1769-7123 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0923-2508 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Research in Microbiology |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_lineage_names | Elsevier BV |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Research in Microbiology |
| primary_location.landing_page_url | https://doi.org/10.1016/j.resmic.2025.104341 |
| publication_date | 2025-09-01 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W2040559263, https://openalex.org/W2118094416, https://openalex.org/W3045967604, https://openalex.org/W2135788092, https://openalex.org/W2022551884, https://openalex.org/W4399323029, https://openalex.org/W3196444888, https://openalex.org/W4283023479, https://openalex.org/W4389474978, https://openalex.org/W2908695599, https://openalex.org/W4220725268, https://openalex.org/W2910071029, https://openalex.org/W2052575924, https://openalex.org/W2896225064, https://openalex.org/W2000478943, https://openalex.org/W1982662495, https://openalex.org/W1877924530, https://openalex.org/W1985905265, https://openalex.org/W4285798129, https://openalex.org/W2068413871, https://openalex.org/W2013798053, https://openalex.org/W2059260984, https://openalex.org/W2113689947, https://openalex.org/W3003110860, https://openalex.org/W3131969908, https://openalex.org/W2170551349, https://openalex.org/W2138207763, https://openalex.org/W2179438025, https://openalex.org/W2168974130, https://openalex.org/W4396721167, https://openalex.org/W3083406432, https://openalex.org/W4242729757, https://openalex.org/W2099839947, https://openalex.org/W2020962641, https://openalex.org/W4386850656, https://openalex.org/W3205265883, https://openalex.org/W2463615343, https://openalex.org/W4405854843, https://openalex.org/W2497305000, https://openalex.org/W2887668519, https://openalex.org/W2939472135, https://openalex.org/W2415099509, https://openalex.org/W2000047180, https://openalex.org/W4404852424, https://openalex.org/W2058975855, https://openalex.org/W2402226709, https://openalex.org/W2318901692, https://openalex.org/W2080881194, https://openalex.org/W4388124681, https://openalex.org/W2069723623, https://openalex.org/W1915856409, https://openalex.org/W4401175614, https://openalex.org/W2400558032, https://openalex.org/W2975609037 |
| referenced_works_count | 54 |
| abstract_inverted_index.a | 172 |
| abstract_inverted_index.In | 15, 128 |
| abstract_inverted_index.as | 5, 154, 169 |
| abstract_inverted_index.by | 156 |
| abstract_inverted_index.in | 26, 57, 146, 165, 171, 186 |
| abstract_inverted_index.is | 24, 142 |
| abstract_inverted_index.of | 9, 63, 131 |
| abstract_inverted_index.or | 31 |
| abstract_inverted_index.to | 19, 80, 102, 114, 137, 139 |
| abstract_inverted_index.we | 52, 72, 109 |
| abstract_inverted_index.For | 69, 98 |
| abstract_inverted_index.JE2 | 141 |
| abstract_inverted_index.WTA | 151 |
| abstract_inverted_index.and | 65, 76, 96, 119, 159, 198 |
| abstract_inverted_index.are | 1 |
| abstract_inverted_index.for | 7, 160, 182 |
| abstract_inverted_index.one | 122 |
| abstract_inverted_index.the | 27, 37, 41, 45, 81, 89, 105, 115, 132, 161, 180 |
| abstract_inverted_index.ΦK | 120 |
| abstract_inverted_index.Here | 51 |
| abstract_inverted_index.JE2, | 108 |
| abstract_inverted_index.MRSA | 106 |
| abstract_inverted_index.This | 177 |
| abstract_inverted_index.VISA | 58, 133 |
| abstract_inverted_index.acid | 48 |
| abstract_inverted_index.both | 74 |
| abstract_inverted_index.cell | 20, 38 |
| abstract_inverted_index.from | 104 |
| abstract_inverted_index.half | 130 |
| abstract_inverted_index.need | 181 |
| abstract_inverted_index.part | 147 |
| abstract_inverted_index.that | 54 |
| abstract_inverted_index.wall | 21, 39, 46 |
| abstract_inverted_index.when | 86, 189 |
| abstract_inverted_index.with | 12, 88, 121, 149, 196 |
| abstract_inverted_index.ΦK. | 97 |
| abstract_inverted_index.(WTA) | 49 |
| abstract_inverted_index.These | 144 |
| abstract_inverted_index.phage | 43, 61, 126, 167 |
| abstract_inverted_index.shown | 155, 170 |
| abstract_inverted_index.study | 178 |
| abstract_inverted_index.using | 193 |
| abstract_inverted_index.which | 140 |
| abstract_inverted_index.(MRSA) | 30 |
| abstract_inverted_index.(VISA) | 34 |
| abstract_inverted_index.Phages | 0 |
| abstract_inverted_index.Stab20 | 138 |
| abstract_inverted_index.Stab21 | 95, 118 |
| abstract_inverted_index.affect | 60 |
| abstract_inverted_index.became | 135 |
| abstract_inverted_index.common | 25 |
| abstract_inverted_index.model. | 176 |
| abstract_inverted_index.phages | 116 |
| abstract_inverted_index.strain | 123, 163 |
| abstract_inverted_index.Stab20, | 94 |
| abstract_inverted_index.adapted | 101 |
| abstract_inverted_index.altered | 150 |
| abstract_inverted_index.anchors | 40 |
| abstract_inverted_index.aureus, | 17 |
| abstract_inverted_index.changes | 145 |
| abstract_inverted_index.evolved | 67 |
| abstract_inverted_index.phages. | 199 |
| abstract_inverted_index.primary | 42 |
| abstract_inverted_index.serious | 10 |
| abstract_inverted_index.strain, | 107 |
| abstract_inverted_index.strains | 71, 85, 100, 134 |
| abstract_inverted_index.therapy | 168 |
| abstract_inverted_index.viruses | 3 |
| abstract_inverted_index.Galleria | 173 |
| abstract_inverted_index.becoming | 124 |
| abstract_inverted_index.clinical | 70 |
| abstract_inverted_index.compared | 79 |
| abstract_inverted_index.infected | 87 |
| abstract_inverted_index.observed | 73, 110 |
| abstract_inverted_index.patterns | 153 |
| abstract_inverted_index.relevant | 91 |
| abstract_inverted_index.resulted | 164 |
| abstract_inverted_index.strains. | 35, 68 |
| abstract_inverted_index.teichoic | 47 |
| abstract_inverted_index.variable | 111 |
| abstract_inverted_index.ancestral | 82 |
| abstract_inverted_index.bacterial | 2, 187 |
| abstract_inverted_index.contrast, | 129 |
| abstract_inverted_index.decreased | 77 |
| abstract_inverted_index.increased | 75 |
| abstract_inverted_index.infection | 175 |
| abstract_inverted_index.mutations | 55 |
| abstract_inverted_index.receptor, | 44 |
| abstract_inverted_index.resistant | 29, 162 |
| abstract_inverted_index.resulting | 56 |
| abstract_inverted_index.targeting | 22 |
| abstract_inverted_index.therapies | 192 |
| abstract_inverted_index.treatment | 8 |
| abstract_inverted_index.antibodies | 158 |
| abstract_inverted_index.clinically | 64 |
| abstract_inverted_index.completely | 125 |
| abstract_inverted_index.considered | 4 |
| abstract_inverted_index.correlated | 148 |
| abstract_inverted_index.developing | 190 |
| abstract_inverted_index.highlights | 179 |
| abstract_inverted_index.infections | 11 |
| abstract_inverted_index.laboratory | 66, 99 |
| abstract_inverted_index.mellonella | 174 |
| abstract_inverted_index.pathogens. | 14 |
| abstract_inverted_index.physiology | 188 |
| abstract_inverted_index.resistance | 18, 112 |
| abstract_inverted_index.resistant. | 127, 143 |
| abstract_inverted_index.treatments | 195 |
| abstract_inverted_index.vancomycin | 83, 103 |
| abstract_inverted_index.alterations | 185 |
| abstract_inverted_index.antibiotics | 23, 197 |
| abstract_inverted_index.combination | 194 |
| abstract_inverted_index.compromised | 166 |
| abstract_inverted_index.demonstrate | 53 |
| abstract_inverted_index.development | 59, 113 |
| abstract_inverted_index.methicillin | 28 |
| abstract_inverted_index.myoviruses, | 92 |
| abstract_inverted_index.phage-based | 191 |
| abstract_inverted_index.susceptible | 33, 84, 136 |
| abstract_inverted_index.Furthermore, | 36 |
| abstract_inverted_index.WTA-specific | 157 |
| abstract_inverted_index.therapeutics | 6 |
| abstract_inverted_index.ΦIPLA-RODI, | 93, 117 |
| abstract_inverted_index.glycosylation | 152 |
| abstract_inverted_index.understanding | 183 |
| abstract_inverted_index.Staphylococcus | 16 |
| abstract_inverted_index.glycopolymers. | 50 |
| abstract_inverted_index.susceptibility | 62, 78 |
| abstract_inverted_index.therapeutically | 90 |
| abstract_inverted_index.antibiotic-driven | 184 |
| abstract_inverted_index.antibiotic-resistant | 13 |
| abstract_inverted_index.vancomycin-intermediate | 32 |
| cited_by_percentile_year | |
| countries_distinct_count | 3 |
| institutions_distinct_count | 6 |
| citation_normalized_percentile.value | 0.51493296 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |